Acne drug Roaccutane at center of new controversy
Main Category: Pregnancy / ObstetricsArticle Date: 26 Apr 2004 - 0:00 PDT
email to a friend 
printer friendly 
opinions
|
|
| Patient / Public: |  |
4.13 (8 votes) |
| Healthcare Prof: |  |
Roche's powerful new cure for acne, Roaccutane, which is thought to have serious side-effects, is at the centre of fresh controversy following the publication of another study into the drug that notes the drug causes serious foetal abnormalities.
Roche says the drug should only be given to women if they have had a negative pregnancy test within two weeks of starting treatment, yet research carried out by the Acne Support Group (UK) showed that more than two thirds of women surveyed who had been prescribed the drug had not been offered a pregnancy test by their doctors.
As well as foetal abnormalities, the drug can cause skin and eye problems, aches and pains and depression.
Visit our pregnancy / obstetrics section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/7675.php>
APA
http://www.medicalnewstoday.com/releases/7675.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
